Amyotrophic lateral sclerosis with laboratory abnormalities of uncertain significance: A brief review
- PMID: 24250855
- PMCID: PMC3829236
Amyotrophic lateral sclerosis with laboratory abnormalities of uncertain significance: A brief review
Abstract
Amyotrophic lateral sclerosis (ALS), the most common form of motor neuron disease, is a progressive and devastating disease involving both lower and upper motor neurons, typically following a relentless progression towards death. Therefore, all efforts must be made by the clinician to exclude alternative and more treatable entities. ALS with laboratory abnormalities of uncertain significance is a subgroup of ALS that occurs in association with laboratory defined abnormalities that are of uncertain significance to the pathogenesis of ALS. The clinical utility of these abnormalities and what they ultimately mean in patients with ALS is discussed here, along with a review of the literature.
Keywords: Amyotrophic Lateral Sclerosis; Laboratory Abnormality; Motor Neuron Disease.
Similar articles
-
Amyotrophic lateral sclerosis-motor neuron disease, monoclonal gammopathy, hyperparathyroidism, and B12 deficiency: case report and review of the literature.J Med Case Rep. 2010 Sep 1;4:298. doi: 10.1186/1752-1947-4-298. J Med Case Rep. 2010. PMID: 20809955 Free PMC article.
-
[Objective markers for upper motor neuron involvement in amyotrophic lateral sclerosis].Brain Nerve. 2007 Oct;59(10):1053-64. Brain Nerve. 2007. PMID: 17969345 Review. Japanese.
-
Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.J Neurosci. 2014 Nov 19;34(47):15587-600. doi: 10.1523/JNEUROSCI.2037-14.2014. J Neurosci. 2014. PMID: 25411487 Free PMC article.
-
Extra-motor abnormalities in amyotrophic lateral sclerosis: another layer of heterogeneity.Expert Rev Neurother. 2017 Jun;17(6):561-577. doi: 10.1080/14737175.2017.1273772. Epub 2017 Jan 3. Expert Rev Neurother. 2017. PMID: 27983884 Review.
-
Sensory nerve disturbance in amyotrophic lateral sclerosis.Life Sci. 2018 Jun 15;203:242-245. doi: 10.1016/j.lfs.2018.04.052. Epub 2018 Apr 27. Life Sci. 2018. PMID: 29709651 Review.
Cited by
-
Pulmonary function tests in patients with amyotrophic lateral sclerosis and the association between these tests and survival.Iran J Neurol. 2014 Jul 4;13(3):131-7. Iran J Neurol. 2014. PMID: 25422731 Free PMC article.
-
Amyotrophic lateral sclerosis mimic syndromes.Iran J Neurol. 2016 Apr 3;15(2):85-91. Iran J Neurol. 2016. PMID: 27326363 Free PMC article. Review.
References
-
- Forbes RB, Colville S, Parratt J, et al. The incidence of motor nueron disease in Scotland. J Neurol. 2007;254:866–9. - PubMed
-
- O'Toole O, Traynor BJ, Brennan P, et al. Epidemiology and clinical features of amyotrophic lateralsclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry. 2008;79:30–2. - PubMed
-
- Brooks B.R. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial “Clinical limits of amyotrophic lateral sclerosis” workshop contributors. J. Neurol. Sci. 1994;1(124) Suppl:96–107. - PubMed
-
- Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous